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Humanskinequivalentasanalternativetoanimaltesting
Äquivalente menschlicher Haut als Alternative zum Tierversuch
Abstract
The 3-D skin equivalent can be viewed as physiologically comparable
to the natural skin and therefore is a suitable alternative for animal
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testing. This highly differentiated in vitro human skin equivalent is used
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to assess the efficacy and mode of action of novel agents. This model
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1 isgeneratedfromprimaryhumankeratinocytesonacollagensubstrate
containing human dermal fibroblasts. It is grown at the air-liquid inter-
face which allows full epidermal stratification and epidermal-dermal
interactions to occur. 1 Fraunhofer Institute of
Interfacial Engineering and Future emphasis is the establishment of different test systems to
investigate wound healing, melanoma research and infection biology.
Biotechnology, Department
Cell Systems, Stuttgart,
Germany Key features of this skin model are that it can be used as an alternative
forinvivostudies,donortissuecanbetailoredtotheneedsofthestudy
and multiple analyses can be carried out at mRNA and protein level.
Driven by both ethical and economical incentives, this has already re-
sulted in a shift of the test strategies used by the Pharmaceutical In-
dustry in the early drug development process as reflected by the in-
creaseddemandforapplicationofcellbasedassays.Itisalsoasuitable
model for testing a wide variety of endpoints including cell viability, the
release of proinflammatory mediators, permeation rate, proliferation
and biochemical changes.
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Zusammenfassung
3-D-Hautäquivalente sind physiologisch vergleichbar mit natürlicher
Haut und deshalb eine Alternative zum Tierversuch. Das hoch differen-
zierte in-vitro Modell menschlicher Haut wird zur Prüfung der Wirksam-
keit und des Wirkungsmechanismus neuer Wirkstoffe eingesetzt. Es
wirdausprimärenmenschlichenKeratinozytenaufeinemKollagensub-
strat, das menschliche dermale Fibroblasten enthält, generiert und
wächst an einer Luft-Wasser-Grenzschicht, die eine komplette epider-
male Stratifikation und epidermal-dermale Interaktion gewährleistet.
ZukünftigerSchwerpunktistdieEtablierungverschiedenerTestsysteme
zum Studium der Wundheilung, der Melanomforschung und der Infek-
tionsbiologie.DasSchlüsselmerkmaldesHautmodellsistseinealterna-
tive Nutzbarkeit für in-vivo-Studien; Spendergewebe können auf die
spezifische Fragestellung zugeschnitten werden und es sind multiple
Analysen an mRNA und Proteinen möglich.
SowohlunterethischenalsauchunterökonomischenGesichtspunkten
ergibt sich damit eine grundlegende Veränderung in der Teststrategie
der Pharmazeutischen Industrie im frühen Entwicklungsstadium der
Arzneimittelentwicklung mit erweiterten Möglichkeiten zur Anwendung
zellbasierter Assays. Das 3-D-Hautäquivalent ist ferner zur Erfassung
einer großen Breite sog. Endpunkte geeignet wie Zellviabilität, Freiset-
zung proinflammatorischer Mediatoren, Permeationsrate, Proliferation
und biochemische Veränderungen.
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Tissueengineeringisaninterdisciplinaryfieldthatapplies
theprinciplesofengineeringandthelifesciencestoward
the development of biological substitutes that restore,
maintain,orimprovetissuefunction.Itoffersthepotential
to create replacement structures from biodegradable
scaffoldsandautologouscellsforreconstructivesurgery.
Thelivingskinequivalent,athree-dimensionalorganotyp-
ic model, has been widely used to investigate many as-
pects of cutaneous biology. Reconstructed human skin
equivalents are the models that most closely mimic nor-
mal human skin. They allow the topical application and
skin irritancy testing of a great variety of products used
in daily life. The major requirements for skin penetration
screening are the presence of a competent skin barrier.
In native skin the first barrier function is carried out by
the outside layer of the skin, the stratum corneum. The
second barrier is the basement membrane In studies
with skin equivalent cultures, it has become evident that
thistwobarrierfunctionisaffected.Itisuntilnowunclear
whether nanoparticles will penetrate the skin.
Some manufacturers of consumer products, particularly
cosmetics, and perhaps in the future foodstuffs, may
utilise the advantages derived from including particulate
materials in nano size in these products to give improved
or additional functionality. These nanoparticles will be
free rather than fixed, although their reactivity (and thus
toxicity)maybeinfluencedbycoatings.Basicallycosmetic
productsisanareawherenanoparticlesofoxidesofzinc,
titanium and iron are being used, and where there are
concernsthattheymightpenetratethroughtheprotective
layers of the skin and cause reactions with UV light that
resultindamagetoDNAinskincells.Andthesecorrosion
causes in higher irritation potential of cosmetic products
or in early skin aging.
Methods
Design of the basic 3-D skin model
The development of a skin model requires firstly the
isolation and growth of dermal fibroblasts and epidermal
keratinocytes from human bioptic tissues. This highly
differentiated in vitro human skin equivalent model is
used to assess the efficacy and mode of action of novel
agents. The skin equivalent is generated from primary
humankeratinocytesonacollagengelsubstratecontain-
ing human dermal fibroblasts. It is grown at the air-liquid
interface which allows full epidermal stratification and
epidermal-dermal interactions to occur.
Figure 1 demonstrates the natural skin in comparison
with the skin equivalent.
Figure 1: Histological cross section of human skin, and of the
three dimensional skin equivalent with stratum corneum
Immunohistochemical staining for cell characterization
was performed by use of the avidin-biotin-peroxidase
technique. Keratinocytes were characterized by the ex-
pression of Keratin 10, 14, 19, Filaggrin and Involucrin.
Streptavidin-peroxidaseconjugatewasapplied,andfinal
staining was performed with diaminobenzidine.
Results and discussion
We applied our skin equivalent in many different areas
such as:
1. Using the skin equivalent for in-vitro toxicity tests
The irritation effect of different test substances was
examined after topical application of the samples on the
surface of the skin equivalent. A cell damage which can
be attributed to the substance was photometrically
quantified over the reduction from non toxic Tetrazolium
salt to water-soluble Formazan (Figure 2).
Figure 2: Histological cross section: control (A) after 20% SDS-
application for 2 sec (B), 30 sec (C) and 90 sec (D)
2. Using the skin equivalent as an in-vitro tumor model
The invasion of malignant cells in normal tissues is a
fundamental characteristic for progressing and the
formationofmetastases.Inordertosimulatetheinvasion
in vitro, different tumor cell lines are co-cultivated.
Therefore it is possible to analyze the same influencing
variablessuchasgrowthfactorsontheinvasionbehavior
of tumors and to test possible therapeutics (e.g. inhibi-
tors) (Figure 3).
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Figure 4: Different strains of Candida albicans and their potential to penetrate the skin
Figure 5: Wound healing process after injury with a laser
3. Using the skin equivalent for testing in-vitro infection
Infectionofthereconstitutedskin(A)withaclinicalisolate
of C. albicans (B) and an avirulent strain (C). The clinical
strain penetrates the protective layer of keratinocytes
and invades through the epithelial cell layers into the
matrix,leadingtodisintegrationofthemodelsystemafter
48 h (B). The avirulent mutants do not form hyphae and
show no ability to invade the tissue. Candida albicans
wasonlydetectedonthetissuesurface(C).Theinfection
modelscanalsobeappliedfordrugscreening[1](Figure
4).
4.Usingtheskinequivalentasanin-vitrowoundhealing
model
A wound could be initiated by mechanical effect of an
Erb:YAG laser in the artificial skin. The defective region
wasactivatedbystimulatedkeratinocytesoftheepiderm-
is to refill the wound (Figure 5). Parallel the IL-1α expres-
sion was measured during the wound healing in the me-
dium by ELISA (Figure 6). Uninjured skin equivalents
served as controls.
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By the physiological similarity with the natural skin the
3-D human skin equivalent is suitable as a test system
for:
• determination of the irritation potential of different
substances
• pharmacological analysis (e.g. wound healing)
• analysis of infection and invasion of different patholo-
gical microorganisms
• target screening
• immunological, histological and molecular-biological
analysis
• proof of efficacy and quality control
• penetration- und permeation studies
• development of bio-chips for tumor diagnostics or
other skin diseases
• development of medical devices, e.g. laser assisted
diagnostic device for melanoma
Pharmaceuticalresearch is hampered by limited predict-
ive value of routinely applied in vitro and in vivo drug
screening models for clinical efficacy. In drug develop-
ment, the common approach of pharmaceuticalindustry
is to screen small-molecule libraries for function and
toxicity in biochemical based or ligand binding high
throughput essays [2]. In general enzymes and 2-dimen-
sional cell lines are used in those cell-based assays. The
obtainedresultsareoflimitedbiologicalrelevance,since
the 2-dimensional cell systems do not adequately mimic
the 3-dimensional environment in healthy and tumour
tissues [3].
Thismodeloffersthepossibilitytosimulatephysiological
drug application and a human 3-D test system to estab-
lished nanomaterials/systems for cancer research/ther-
apy.
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